U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07835061) titled 'AI-CIMCare Chatbot" to Enhance Complementary and Integrative Medicine (CIM)' on Sept. 07.
Brief Summary: Performance analysis of the AI-CIMCare Chatbot is an essential way to ensure its impact on the promotion of patient-based outcomes in patients with diabetes.
Study Start Date: Aug. 05
Study Type: INTERVENTIONAL
Condition:
Diabetes
Intervention:
BEHAVIORAL: AI-CIMCare Chatbot
The intervention will be carried out over a 12-week period, which contains four sections: (1) knowledge on benefit-risk assessment of CIM use; (2) short videos regarding information and skills necessary to seek, assess; (3) evaluate how to be critical...